It was noted that the device is not available for evaluation.Should additional information become available, it will be provided in a supplemental report upon completion of the investigation.Voluntary recall ra 2012-067 was initiated for abgii and rejuvenate modular stems and necks due to the potential risks associated with these devices.The reported elevated levels is considered to be under the scope of this recall.No further investigation is required.Although no catalog number or lot code was provided, similar events have occurred for the product family.These events were determined to be associated with ra 2012-067.H3 other text : device not returned to the manufacturer.
|
"i am a patient who was implanted with the abg ii hip prosthesis in 2013.Following the use of this medical device, i have experienced numerous health problems such as autoimmune hemolytic anemia, hypothyroidism, premature menopause, ovarian failure, heart failure, cardiomyopathy, sensorineural deafness and atopic dermatitis.I performed revisions in 2019 & 2020 and the only remaining part of the implanted prosthesis in 2013 was the stem of the abg ii prosthesis.During the recent revision in 2023, it was necessary to remove this remaining part of the prosthesis.This discovery was made in (b)(6) 2022, when it was found that i was exposed to high levels of cobalt, with a maximum value of 1550.I found out that the abg ii prothesis was recalled in 2012 and then implanted to me in 2013.".
|